Side effects during chemotherapy predict tumour response in advanced colorectal cancer

被引：0
|
作者：
Fink, Michael
机构：
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2006年 / 182卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：687 / 689
页数：3
相关论文
共 50 条
  • [21] THE VALUE OF MORPHOMETRY TO PREDICT CHEMOTHERAPY RESPONSE IN ADVANCED OVARIAN-CANCER
    WEGER, AR
    LUDESCHER, C
    MIKUZ, G
    KEMMLER, G
    REITSAMER, R
    HAUSMANINGER, H
    LINDHOLM, J
    PATHOLOGY RESEARCH AND PRACTICE, 1989, 185 (05) : 676 - 679
  • [22] Chinese medical herbs for chemotherapy side effects in colorectal cancer patients
    Wu, TX
    Munro, AJ
    Guanjian, L
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (01):
  • [23] MRI radiomics to predict tumour response in patients with locally advanced rectal cancer
    Bulens, P.
    Couwenberg, A.
    Intven, M.
    Debucquoy, A.
    Vandecaveye, V.
    Philippens, M.
    Mukherjee, P.
    Gevaert, O.
    Haustermans, K.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S265 - S266
  • [24] MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer
    Molina-Pinelo, Sonia
    Carnero, Amancio
    Rivera, Fernando
    Estevez-Garcia, Purificacion
    Bozada, Juan Manuel
    Limon, Maria Luisa
    Benavent, Marta
    Gomez, Javier
    Pastor, Maria Dolores
    Chaves, Manuel
    Suarez, Rocio
    Paz-Ares, Luis
    de la Portilla, Fernando
    Carranza-Carranza, Andres
    Sevilla, Isabel
    Vicioso, Luis
    Garcia-Carbonero, Rocio
    BMC CANCER, 2014, 14
  • [25] MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer
    Sonia Molina-Pinelo
    Amancio Carnero
    Fernando Rivera
    Purificacion Estevez-Garcia
    Juan Manuel Bozada
    Maria Luisa Limon
    Marta Benavent
    Javier Gomez
    Maria Dolores Pastor
    Manuel Chaves
    Rocio Suarez
    Luis Paz-Ares
    Fernando de la Portilla
    Andres Carranza-Carranza
    Isabel Sevilla
    Luis Vicioso
    Rocio Garcia-Carbonero
    BMC Cancer, 14
  • [26] Tumour Characteristics Determining Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
    Turna, Z. Savas
    Ozturk, M. A.
    Tural, D.
    Biricik, F. S.
    Yildiz, O.
    Ozguroglu, M. A.
    Demirelli, F.
    Mandel, N. M.
    Buyukunal, E.
    Serdengecti, S.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S344 - S344
  • [27] DOES RESPONSE TO ENDOCRINE THERAPY PREDICT RESPONSE TO CHEMOTHERAPY IN ADVANCED BREAST-CANCER
    STEINER, R
    STEWART, JF
    RUBENS, RD
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 143 - 143
  • [28] Use of microsatellite instability in non-hereditary advanced colorectal cancer to predict response to chemotherapy and overall survival: A study of the Dutch Colorectal Cancer Group (DCCG)
    Koopman, M.
    Kortman, G. A.
    Mekenkamp, L.
    Ligtenberg, M. J.
    Hoogerbrugge, N.
    Mol, L.
    Antonini, N. F.
    Punt, C. J.
    van Krieken, J. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [29] Mismatch repair status is a predictive factor of tumour response to 5-fluorouracil and irinotecan chemotherapy in patients with advanced colorectal cancer
    Bendardaf, R.
    Lamlum, H.
    Ristamaki, R.
    Korkeila, E.
    Syrjanen, K.
    Pyrhonen, S.
    TUMOR BIOLOGY, 2007, 28 (04) : 212 - 220
  • [30] Prognostic phenotypic subtypes to predict recurrence and response to adjuvant chemotherapy for colorectal cancer
    Roseweir, Antonia K.
    Park, James Hugh
    ten Hoorn, Sanne
    Powell, Arfon G. M. T.
    Aherne, Susan
    Roxburgh, Campbell S. D.
    McMillan, Donald C.
    Horgan, Paul G.
    Ryan, Elizabeth
    Sheahan, Keiran
    Vermeulen, Louis
    Paul, James
    Graham, Janet Shirley
    Sansom, Owen
    Church, David
    Iveson, Timothy
    Edwards, Joanne
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
12345